| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 728971 | 1201439010 | ATECTURA BREEZHALER 125 microgramos/260 microgramos POLVO PARA INHALACION (CAPSULA DURA) | ATECTURA BREEZHALER 125 microgramos/260 microgramos POLVO PARA INHALACION (CAPSULA DURA), 30 x 1 cápsulas (dosis unitaria) + 1 inhalador | 125 microgramos/260 microgramos/dosis | 5 | 30 | 8 | 30 x 1 cápsulas (dosis unitaria) + 1 inhalador | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201439010/1201439010_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201439010/1201439010_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | LABORATORIOS MENARINI S.A. | 2020-08-10 | 1 | 1 | 1 | 2020-08-11 | 2020-08-10 | 1 | 2021-11-11 | View Edit Delete | ||||||||||||
| 729880 | 1201440002 | ZIMBUS BREEZHALER 114 microgramos/46 microgramos/136 microgramos POLVO PARA INHALACION (CAPSULA DURA) | ZIMBUS BREEZHALER 114 microgramos/46 microgramos/136 microgramos POLVO PARA INHALACION (CAPSULA DURA), 30 cápsulas + 1 inhalador | 114 microgramos/46 microgramos/136 microgramos | 5 | 30 | 8 | 30 cápsulas + 1 inhalador | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201440002/1201440002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201440002/1201440002_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | LABORATORIOS GEBRO PHARMA S.A. | 2020-12-16 | 1 | 1 | 1 | 2020-12-17 | 2020-12-16 | 1 | 2022-03-07 | View Edit Delete | ||||||||||||
| 729877 | 1201441002 | BEMRIST BREEZHALER 125 microgramos/62,5 microgramos POLVO PARA INHALACION (CAPSULA DURA) | BEMRIST BREEZHALER 125 microgramos/62,5 microgramos POLVO PARA INHALACION (CAPSULA DURA), 30 cápsulas+ 1 inhalador | 125 microgramos/62,5 microgramos/dosis | 5 | 30 | 8 | 30 cápsulas+ 1 inhalador | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201441002/1201441002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201441002/1201441002_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2020-12-16 | 1 | 1 | 1 | 2020-12-17 | 2020-12-17 | 1 | 2021-11-11 | View Edit Delete | ||||||||||||
| 729878 | 1201441006 | BEMRIST BREEZHALER 125 microgramos/127,5 microgramos POLVO PARA INHALACION (CAPSULA DURA) | BEMRIST BREEZHALER 125 microgramos/127,5 microgramos POLVO PARA INHALACION (CAPSULA DURA), 30 cápsulas+ 1 inhalador | 125 microgramos/127,5 microgramos/dosis | 5 | 30 | 8 | 30 cápsulas+ 1 inhalador | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201441006/1201441006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201441006/1201441006_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | LABORATORIOS GEBRO PHARMA S.A. | 2020-12-16 | 1 | 1 | 1 | 2020-12-17 | 2020-12-17 | 1 | 2021-11-11 | View Edit Delete | ||||||||||||
| 729879 | 1201441010 | BEMRIST BREEZHALER 125 microgramos/260 microgramos POLVO PARA INHALACION (CAPSULA DURA) | BEMRIST BREEZHALER 125 microgramos/260 microgramos POLVO PARA INHALACION (CAPSULA DURA), 30 cápsulas + 1 inhalador | 125 microgramos/260 microgramos/dosis | 5 | 30 | 8 | 30 cápsulas + 1 inhalador | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201441010/1201441010_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201441010/1201441010_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | LABORATORIOS GEBRO PHARMA S.A. | 2020-12-16 | 1 | 1 | 1 | 2020-12-17 | 2020-12-17 | 1 | 2021-11-11 | View Edit Delete | ||||||||||||
| 728769 | 1201442001 | ZEPOSIA 0,23 MG/0,46 MG CAPSULAS DURAS | ZEPOSIA 0,23 MG/0,46 MG CAPSULAS DURAS 7 cápsulas (4 x 0,23 mg, 3 x 0,46 mg) | 0,23 mg + 0,46 mg | 5 | 7 | 43 | 7 cápsulas (4 x 0,23 mg, 3 x 0,46 mg) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201442001/1201442001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201442001/1201442001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 31892 | BRISTOL MYERS SQUIBB S.A. | 2020-06-25 | 1 | 1 | 1 | 2020-06-26 | 2020-06-25 | 1 | 2022-05-14 | View Edit Delete | ||||||||||||
| 728770 | 1201442002 | ZEPOSIA 0,92 MG CAPSULAS DURAS | ZEPOSIA 0,92 MG CAPSULAS DURAS 28 cápsulas | 0,92 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201442002/1201442002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201442002/1201442002_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 31892 | BRISTOL MYERS SQUIBB S.A. | 2020-06-25 | 1 | 1 | 1 | 2020-06-26 | 2020-06-25 | 1 | 2022-05-14 | View Edit Delete | ||||||||||||
| 728554 | 1201443001 | ZOLGENSMA 2 x 10e13 GENOMAS VECTORIALES/ML SOLUCION PARA PERFUSION | ZOLGENSMA 2 x 10e13 GENOMAS VECTORIALES/ML SOLUCION PARA PERFUSION, 2 viales de 8,3 ml | 2 x 10e13 genomas vectoriales/ml inyectable 8,3 ml | 45 | 2 | 34 | 2 viales de 8,3 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1201443001/1201443001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201443001/1201443001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2020-07-28 | 1 | 1 | 1 | 2020-07-29 | 2020-07-28 | 1 | 2021-11-15 | View Edit Delete | ||||||||||||
| 728555 | 1201443001 | ZOLGENSMA 2 x 10e13 GENOMAS VECTORIALES/ML SOLUCION PARA PERFUSION | ZOLGENSMA 2 x 10e13 GENOMAS VECTORIALES/ML SOLUCION PARA PERFUSION, 2 viales de 5,5 ml y 1 vial 8,3 ml | 2 x 10e13 genomas vectoriales/ml inyectable | 45 | 3 | 34 | 2 viales de 5,5 ml y 1 vial 8,3 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1201443001/1201443001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201443001/1201443001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2020-07-28 | 1 | 1 | 1 | 2020-07-29 | 2020-07-28 | 1 | 2021-11-15 | View Edit Delete | ||||||||||||
| 728556 | 1201443001 | ZOLGENSMA 2 x 10e13 GENOMAS VECTORIALES/ML SOLUCION PARA PERFUSION | ZOLGENSMA 2 x 10e13 GENOMAS VECTORIALES/ML SOLUCION PARA PERFUSION, 1 vial de 5,5 ml y 2 viales de 8,3 ml | 2 x 10e13 genomas vectoriales/ml inyectable | 45 | 3 | 34 | 1 vial de 5,5 ml y 2 viales de 8,3 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1201443001/1201443001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201443001/1201443001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2020-07-28 | 1 | 1 | 1 | 2020-07-29 | 2020-07-28 | 1 | 2021-11-15 | View Edit Delete | ||||||||||||
| 728557 | 1201443001 | ZOLGENSMA 2 x 10e13 GENOMAS VECTORIALES/ML SOLUCION PARA PERFUSION | ZOLGENSMA 2 x 10e13 GENOMAS VECTORIALES/ML SOLUCION PARA PERFUSION, 3 viales de 8,3 ml | 2 x 10e13 genomas vectoriales/ml inyectable 8,3 ml | 45 | 3 | 34 | 3 viales de 8,3 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1201443001/1201443001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201443001/1201443001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2020-07-28 | 1 | 1 | 1 | 2020-07-29 | 2020-07-28 | 1 | 2021-11-15 | View Edit Delete | ||||||||||||
| 728558 | 1201443001 | ZOLGENSMA 2 x 10e13 GENOMAS VECTORIALES/ML SOLUCION PARA PERFUSION | ZOLGENSMA 2 x 10e13 GENOMAS VECTORIALES/ML SOLUCION PARA PERFUSION, 2 viales de 5,5 ml y 2 viales de 8,3 ml | 2 x 10e13 genomas vectoriales/ml inyectable | 45 | 4 | 34 | 2 viales de 5,5 ml y 2 viales de 8,3 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1201443001/1201443001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201443001/1201443001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2020-07-28 | 1 | 1 | 1 | 2020-07-29 | 2020-07-28 | 1 | 2021-11-15 | View Edit Delete | ||||||||||||
| 728559 | 1201443001 | ZOLGENSMA 2 x 10e13 GENOMAS VECTORIALES/ML SOLUCION PARA PERFUSION | ZOLGENSMA 2 x 10e13 GENOMAS VECTORIALES/ML SOLUCION PARA PERFUSION, 1 vial de 5,5 ml y 3 viales de 8,3 ml | 2 x 10e13 genomas vectoriales/ml inyectable | 45 | 4 | 34 | 1 vial de 5,5 ml y 3 viales de 8,3 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1201443001/1201443001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201443001/1201443001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2020-07-28 | 1 | 1 | 1 | 2020-07-29 | 2020-07-28 | 1 | 2021-11-15 | View Edit Delete | ||||||||||||
| 728560 | 1201443001 | ZOLGENSMA 2 x 10e13 GENOMAS VECTORIALES/ML SOLUCION PARA PERFUSION | ZOLGENSMA 2 x 10e13 GENOMAS VECTORIALES/ML SOLUCION PARA PERFUSION, 4 viales de 8,3 ml | 2 x 10e13 genomas vectoriales/ml inyectable 8,3 ml | 45 | 4 | 34 | 4 viales de 8,3 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1201443001/1201443001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201443001/1201443001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2020-07-28 | 1 | 1 | 1 | 2020-07-29 | 2020-07-28 | 1 | 2021-11-15 | View Edit Delete | ||||||||||||
| 728561 | 1201443001 | ZOLGENSMA 2 x 10e13 GENOMAS VECTORIALES/ML SOLUCION PARA PERFUSION | ZOLGENSMA 2 x 10e13 GENOMAS VECTORIALES/ML SOLUCION PARA PERFUSION, 2 viales de 5,5 ml y 3 viales de 8,3 ml | 2 x 10e13 genomas vectoriales/ml inyectable | 45 | 5 | 34 | 2 viales de 5,5 ml y 3 viales de 8,3 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1201443001/1201443001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201443001/1201443001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2020-07-28 | 1 | 1 | 1 | 2020-07-29 | 2020-07-28 | 1 | 2021-11-15 | View Edit Delete | ||||||||||||
| 728562 | 1201443001 | ZOLGENSMA 2 x 10e13 GENOMAS VECTORIALES/ML SOLUCION PARA PERFUSION | ZOLGENSMA 2 x 10e13 GENOMAS VECTORIALES/ML SOLUCION PARA PERFUSION, 1 vial de 5,5 ml y 4 viales de 8,3 ml | 2 x 10e13 genomas vectoriales/ml inyectable | 45 | 5 | 34 | 1 vial de 5,5 ml y 4 viales de 8,3 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1201443001/1201443001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201443001/1201443001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2020-07-28 | 1 | 1 | 1 | 2020-07-29 | 2020-07-28 | 1 | 2021-11-15 | View Edit Delete | ||||||||||||
| 728563 | 1201443001 | ZOLGENSMA 2 x 10e13 GENOMAS VECTORIALES/ML SOLUCION PARA PERFUSION | ZOLGENSMA 2 x 10e13 GENOMAS VECTORIALES/ML SOLUCION PARA PERFUSION, 5 viales de 8,3 ml | 2 x 10e13 genomas vectoriales/ml inyectable 8,3 ml | 45 | 5 | 34 | 5 viales de 8,3 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1201443001/1201443001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201443001/1201443001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2020-07-28 | 1 | 1 | 1 | 2020-07-29 | 2020-07-28 | 1 | 2021-11-15 | View Edit Delete | ||||||||||||
| 728564 | 1201443001 | ZOLGENSMA 2 x 10e13 GENOMAS VECTORIALES/ML SOLUCION PARA PERFUSION | ZOLGENSMA 2 x 10e13 GENOMAS VECTORIALES/ML SOLUCION PARA PERFUSION, 2 viales de 5,5 ml y 4 viales de 8,3 ml | 2 x 10e13 genomas vectoriales/ml inyectable | 45 | 6 | 34 | 2 viales de 5,5 ml y 4 viales de 8,3 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1201443001/1201443001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201443001/1201443001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2020-07-28 | 1 | 1 | 1 | 2020-07-29 | 2020-07-28 | 1 | 2021-11-15 | View Edit Delete | ||||||||||||
| 728565 | 1201443001 | ZOLGENSMA 2 x 10e13 GENOMAS VECTORIALES/ML SOLUCION PARA PERFUSION | ZOLGENSMA 2 x 10e13 GENOMAS VECTORIALES/ML SOLUCION PARA PERFUSION, 1 vial de 5,5 ml y 5 viales de 8,3 ml | 2 x 10e13 genomas vectoriales/ml inyectable | 45 | 6 | 34 | 1 vial de 5,5 ml y 5 viales de 8,3 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1201443001/1201443001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201443001/1201443001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2020-07-28 | 1 | 1 | 1 | 2020-07-29 | 2020-07-28 | 1 | 2021-11-15 | View Edit Delete | ||||||||||||
| 728566 | 1201443001 | ZOLGENSMA 2 x 10e13 GENOMAS VECTORIALES/ML SOLUCION PARA PERFUSION | ZOLGENSMA 2 x 10e13 GENOMAS VECTORIALES/ML SOLUCION PARA PERFUSION, 2 viales de 5,5 ml y 5 viales de 8,3 ml | 2 x 10e13 genomas vectoriales/ml inyectable | 45 | 7 | 34 | 2 viales de 5,5 ml y 5 viales de 8,3 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1201443001/1201443001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201443001/1201443001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2020-07-28 | 1 | 1 | 1 | 2020-07-29 | 2020-07-28 | 1 | 2021-11-15 | View Edit Delete |
Page 113 of 1036, showing 20 records out of 20704 total, starting on record 2241, ending on 2260